{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-1.5","upperLimit":"0.0","value":"-0.7"},{"groupId":"OG001","lowerLimit":"-0.2","upperLimit":"1.3","value":"0.6"}]}],"title":"Change from baseline FACIT-Fatigue Score to 6 months"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-1.6","upperLimit":"0.0","value":"-0.8"},{"groupId":"OG001","lowerLimit":"-0.3","upperLimit":"1.2","value":"0.5"}]}],"title":"Change from baseline FACIT-Fatigue Score to 12 months"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.1","upperLimit":"1.7","value":"0.9"},{"groupId":"OG001","lowerLimit":"0.4","upperLimit":"2.0","value":"1.2"}]}],"title":"Change from baseline FACIT-Fatigue Score to 18 months"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.5","upperLimit":"2.1","value":"1.3"},{"groupId":"OG001","lowerLimit":"0.7","upperLimit":"2.4","value":"1.6"}]}],"title":"Change from baseline FACIT-Fatigue Score to 24 months"}],"denoms":[{"counts":[{"groupId":"OG000","value":"382"},{"groupId":"OG001","value":"406"}],"units":"Participants"}],"description":"Change from baseline for FACIT-Fatigue Score at 6, 12, 18 and 24 months for patients who completed adjuvant chemotherapy. Adjusted least-square mean changes and 95% CI are obtained from mixed model for repeated measures (MMRM) analysis of the change from baseline. Only patients with evaluable baseline forms are included. FACIT-Fatigue score ranges from 0 to 52 with higher score indicating less fatigue.","dispersionType":"95% Confidence Interval","groups":[{"description":"Olaparib tablets 300mg taken orally twice daily.","id":"OG000","title":"Olaparib"},{"description":"Placebo tablets taken orally twice daily.","id":"OG001","title":"Placebo"}],"paramType":"MEAN","populationDescription":"Patient reported outcomes (PRO) Analysis Set","reportingStatus":"POSTED","timeFrame":"6, 12, 18 and 24 months after randomisation (data cut off: 12 July 2021)","title":"Change From Baseline for FACIT-Fatigue (Functional Assessment of Chronic Illness Therapy-Fatigue) Score for Participants Who Completed Adjuvant Chemotherapy","type":"SECONDARY","unitOfMeasure":"Scores on a scale"}